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Background & AimsWe compared 5 non-specific and 2 specific blood tests for liver
fibrosis in HCV/HIV co-infection. Methods Four hundred and sixty-seven patients
were included into derivation (n = 183) or validation (n = 284) populations. Within
these populations, the diagnostic target, significant fibrosis (Metavir F ⩾2), was
found in 66% and 72% of the patients, respectively. Two new fibrosis tests,
FibroMeter HICV and HICV test, were constructed in the derivation population.
Results Unadjusted AUROCs in the derivation population were: APRI: 0.716, Fib-4:
0.722, Fibrotest: 0.778, Hepascore: 0.779, FibroMeter: 0.783, HICV test: 0.822,
FibroMeter HICV: 0.828. AUROCs adjusted on classification and distribution of
fibrosis stages in a reference population showed similar values in both populations.
FibroMeter, FibroMeter HICV and HICV test had the highest correct classification
rates in F0/1 and F3/4 (which account for high predictive values): 77–79% vs.
70–72% in the other tests (p = 0.002). Reliable individual diagnosis based on
predictive values ⩾90% distinguished three test categories: poorly reliable: Fib-4
(2.4% of patients), APRI (8.9%); moderately reliable: Fibrotest (25.4%), FibroMeter
(26.6%), Hepascore (30.2%); acceptably reliable: HICV test (40.2%), FibroMeter
HICV (45.6%) (p < 10−3 between tests). FibroMeter HICV classified all patients into
four reliable diagnosis intervals (⩽F1, F1 ± 1, ⩾F1, ⩾F2) with an overall accuracy of
93% vs. 79% (p < 10−3) for a binary diagnosis of significant fibrosis. Conclusions
Tests designed for HCV infections are less effective in HIV/HCV infections. A specific
test, like FibroMeter HICV, was the most interesting test for diagnostic accuracy,
correct classification profile, and a reliable diagnosis. With reliable diagnosis
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